New drug monographs are available
The University Health System Consortium has 17 drug monographs planned for this year. Several new releases are now available. They include:
- Antidiabetic Agents (TD0100)
- Aspirin 25 mg/Extended-Release Dipyridamole 200 mg (TD0900)
- Thrombolytics for Acute Myocardial Infarction (TD0200)
- Etanercept (TD0300)
- COX-2 (TD0400)
- System Pharmacologics for VZV (TD0500)
- Bisphosphonates (TD0600)
The monographs include comprehensive evaluations of drugs that are under review or were recently approved by the Food and Drug Administration, with a special focus on those that may significantly affect patient care and hospital finances.
Each monograph includes a discussion of financial implications and contains information on indications, clinical efficacy, and adverse effects, along with a consideration of alternative drug therapies and recommendations for appropriate use.
An annual subscription for the series is $500, and individual monographs are $50.
For more information, contact the consortium at (630) 954-1700.
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content